Venetoclax Plus Inotuzumab for B-ALL
Clinical trial NCT05016947 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05016947
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-24
- Primary completion
- 2023-07-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.